SK Capital to acquire Perrigo Company’s active pharmaceutical ingredients business
SK Capital, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, is to to acquire Perrigo API, Perrigo Company’s active pharmaceutical ingredients (API) business. As part of the transaction, the parties have agreed to enter into a long-term supply agreement for Perrigo API to supply multiple